Episode Details

In this video, Dr. Mohammed Paika, board-certified in Obesity Medicine and Internal Medicine, shares a real hospital case involving a severe complication shortly after starting Ozempic (a GLP-1 receptor agonist).

An elderly patient presented with abdominal pain, nausea, vomiting, severe hypoglycemia, and acute pancreatitis shortly after being placed on a GLP-1 medication while still on insulin. Dr. Paika explains what happened, how it was treated, and why this case highlights the importance of careful medication management, especially in older adults and patients with diabetes.

This video also breaks down:

• How GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound work
• Common vs serious side effects
• The risk of pancreatitis, hypoglycemia, gastroparesis, gallbladder disease, and bowel obstruction
• The boxed warning for medullary thyroid cancer (MTC) and why patients with MEN-2 should avoid these medications
• What the current Ozempic and GLP-1 lawsuits are really about
• And an empathetic discussion honoring patients who were harmed

This is not fear-based content. These medications help millions of people. But powerful treatments require education, monitoring, and informed consent.

📌 This does not replace medical advice. Patient details have been altered for privacy. Always speak with your healthcare provider before starting or stopping any medication.

If you or someone you love is considering or already using a GLP-1 medication, this video will help you understand the benefits, risks, and warning signs so you can make informed decisions.

⚕️ Medical & Educational Disclaimer

The Dr. Paika Podcast and all related content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information shared is not intended as medical advice and should not be used as a substitute for consultation with your personal physician or qualified healthcare professional.

Listening to this podcast does not create a doctor-patient relationship between you and Dr. Paika.

Health, nutrition, exercise, medication, and weight-management topics discussed may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.

Exercise and lifestyle changes carry inherent risks. By choosing to apply any information from this podcast, you accept full responsibility for your health decisions and outcomes.

Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from the use or application of information presented in this podcast.